<DOC>
	<DOCNO>NCT00033488</DOCNO>
	<brief_summary>RATIONALE : Screening test may help doctor detect cancer cell early plan effective treatment ovarian cancer . PURPOSE : Screening trial determine best procedure detect ovarian cancer woman high genetic risk develop ovarian cancer .</brief_summary>
	<brief_title>Screening Women High Genetic Risk Ovarian Cancer</brief_title>
	<detailed_description>OBJECTIVES : - Determine optimal screen procedure ovarian cancer , term appropriate screen test , criterion interpretation result , screen interval , woman high genetic risk develop ovarian cancer . - Determine physical morbidity resource implication associate ovarian cancer screen woman . - Assess feasibility screen high-risk population term compliance rate . OUTLINE : Patients undergo transvaginal ultrasonography ovary ( schedule early follicular phase , day 3-6 menstrual cycle ) CA 125 measurement annually . Blood sample collect every 4 month analysis CA 125 level novel marker . Peer Reviewed Funded Endorsed Cancer Research UK PROJECTED ACCRUAL : A total 5,000 patient accrue study .</detailed_description>
	<mesh_term>Ovarian Neoplasms</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Firstdegree relative ( mother , sister , daughter ) affect member highrisk family define one following : Family contain 2 individual ovarian cancer connect firstdegree relationship Family contain 1 individual ovarian cancer 1 individual breast cancer 50 year age time diagnosis connect firstdegree relationship Family contain 1 individual ovarian cancer 2 individual breast cancer 60 year age time diagnosis connect firstdegree relationship Family contain affect individual mutation one know ovarian cancer predispose gene Family contain 3 individual colorectal cancer least 1 individual 50 year age time diagnosis 1 individual ovarian cancer connect firstdegree relationship Families affect relative related seconddegree relationship unaffected intervene male relative affect daughter allow PATIENT CHARACTERISTICS : Age : 35 Performance status : Not specify Life expectancy : Not specify Hematopoietic : Not specify Hepatic : Not specify Renal : Not specify PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : Not specify Endocrine therapy : Not specify Radiotherapy : Not specify Surgery : No prior bilateral oophorectomy Other : No concurrent participation ovarian cancer screening trial</criteria>
	<gender>Female</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2007</verification_date>
	<keyword>ovarian epithelial cancer</keyword>
</DOC>